Omada Health, Inc. (OMDA) — SEC Filings
Omada Health, Inc. (OMDA) — 9 SEC filings. Latest: 10-Q (May 8, 2026). Includes 3 10-Q, 3 8-K, 1 DEFA14A.
View Omada Health, Inc. on SEC EDGAR
Overview
Omada Health, Inc. (OMDA) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a DEFA14A filed on Apr 28, 2026: Omada Health, Inc. filed a Definitive Additional Materials (DEFA14A) on April 28, 2026. This filing concerns additional proxy soliciting materials. The company's mailing address is in Dallas, TX, and its business address is in South San Francisco, CA.
Sentiment Summary
Across 9 filings, the sentiment breakdown is: 7 neutral, 2 mixed. The dominant filing sentiment for Omada Health, Inc. is neutral.
Filing Type Overview
Omada Health, Inc. (OMDA) has filed 3 10-Q, 1 DEFA14A, 3 8-K, 1 S-1/A, 1 S-1 with the SEC between May 2025 to May 2026.
Filings by Year
Recent SEC Filings (9)
| Date | Form | Description | Risk |
|---|---|---|---|
| May 8, 2026 | 10-Q | 10-Q Filing | |
| Apr 28, 2026 | DEFA14A | Omada Health Files Additional Proxy Materials | low |
| Nov 7, 2025 | 10-Q | Omada Health Revenue Soars 49% as IPO Boosts Cash, Losses Narrow | medium |
| Nov 6, 2025 | 8-K | 8-K Filing | |
| Aug 8, 2025 | 10-Q | Omada Health Revenue Jumps 25% Amid Widening Net Loss | high |
| Aug 7, 2025 | 8-K | Omada Health Files 8-K on Operations and Financials | low |
| Jun 9, 2025 | 8-K | Omada Health Files 8-K with Corporate Updates | low |
| May 29, 2025 | S-1/A | Omada Health Files S-1/A for IPO, Eyes Public Market Debut | medium |
| May 9, 2025 | S-1 | Omada Health Files S-1 for Public Offering | medium |
Risk Profile
Risk Assessment: Of OMDA's 7 recent filings, 1 were flagged as high-risk, 3 as medium-risk, and 3 as low-risk. The overall risk profile suggests relatively low risk with generally favorable filings.
Financial Highlights
| Metric | Value |
|---|---|
| Revenue | $68,030,000 |
| Net Income | -$3,180,000 |
| EPS | Not Disclosed |
| Debt-to-Equity | 0.03 |
| Cash Position | $198,627,000 |
| Operating Margin | Not Disclosed |
| Total Assets | $287,469,000 |
| Total Debt | $0 |
Key Executives
- Sean Duffy
- Kathleen M. Wells
- Richard Kim
- Josh B. Landis
- Nathan Salha
- Alan F. Denenberg
- Emily Roberts
Industry Context
Omada Health operates in the rapidly growing digital health market, which focuses on using technology to deliver healthcare services and improve patient outcomes. The sector is characterized by increasing adoption of telehealth, remote monitoring, and personalized digital therapeutics. Key trends include a shift towards value-based care, a focus on chronic disease management, and integration with employer wellness programs.
Top Tags
Digital Health (3) · Healthcare Technology (3) · IPO (2) · Revenue Growth (2) · Net Loss (2) · proxy-solicitation (1) · disclosure (1) · Telemedicine (1) · Cardiometabolic Programs (1) · 10-Q Analysis (1)
Key Numbers
| Metric | Value | Context |
|---|---|---|
| Total Revenue (Q3 2025) | $68.03M | Increased 49.4% from $45.52M in Q3 2024 |
| Total Revenue (9M 2025) | $184.36M | Increased 51.3% from $121.82M in 9M 2024 |
| Net Loss (Q3 2025) | $3.18M | Improved from $9.23M net loss in Q3 2024 |
| Net Loss (9M 2025) | $17.94M | Improved from $38.89M net loss in 9M 2024 |
| Cash and Cash Equivalents | $198.63M | As of September 30, 2025, up from $76.39M at December 31, 2024 |
| IPO Proceeds | $160.53M | Net proceeds from initial public offering |
| Common Shares Outstanding | 57,908,047 | As of November 5, 2025 |
| Related Party Service Revenue (Q3 2025) | $41.8M | Represents 66.4% of total service revenue for the quarter |
| Total Revenue | $125.5M | Increased 25.2% for six months ended June 30, 2025, from $100.2M in prior year. |
| Net Loss | $35.8M | Widened from $28.1M in the prior year, indicating increased operational costs. |
| Revenue Growth | 25.2% | Year-over-year increase in total revenue for the six-month period. |
| Service Revenue | $120.3M | Primary revenue driver, up 24.7% from $96.5M in the prior year. |
| Hardware Revenue | $5.2M | Grew 38.5% from $3.7M in the prior year, showing strong segment growth. |
| Accumulated Deficit | $250.1M | Increased from $214.3M at December 31, 2024, highlighting ongoing unprofitability. |
| SEC File Number | 001-42679 | Identifies the specific filing for Omada Health, Inc. |
Related Companies
Frequently Asked Questions
What are the latest SEC filings for Omada Health, Inc. (OMDA)?
Omada Health, Inc. has 9 recent SEC filings from May 2025 to May 2026, including 3 10-Q, 3 8-K, 1 DEFA14A. Each filing includes an AI-generated plain-English summary.
What is the overall sentiment of OMDA filings?
Across 9 filings, the sentiment breakdown is: 7 neutral, 2 mixed. The dominant sentiment is neutral.
Where can I find Omada Health, Inc. SEC filings explained simply?
ReadTheFiling provides AI-powered plain-English summaries of all Omada Health, Inc. (OMDA) SEC filings, including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and insider trades.
What are the key financial highlights for Omada Health, Inc.?
Key financial highlights from Omada Health, Inc.'s most recent 10-Q include metrics such as revenue, net income, EPS, and debt ratios. Visit the filing detail page for the full breakdown.
What is the investment thesis for OMDA?
The investment thesis for OMDA includes bull, base, and bear case scenarios derived from AI analysis of recent SEC filings.
Who are the key executives at Omada Health, Inc.?
Key executives identified across Omada Health, Inc.'s filings include Sean Duffy, Kathleen M. Wells, Richard Kim, Josh B. Landis, Nathan Salha and 2 others.
What are the main risk factors for Omada Health, Inc. stock?
Of OMDA's 7 assessed filings, 1 were flagged high-risk, 3 medium-risk, and 3 low-risk.
What are recent predictions and forward guidance from Omada Health, Inc.?
Forward guidance and predictions for Omada Health, Inc. are extracted from SEC filings as they are enriched.